SCM
SRTAW

Saba Capital Management’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Saba Capital Management’s Portfolio SRTAW Stock Details SRTAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$183 Hold
27,728
– – ﹤0.01% 390
2025
Q4 		$3K Hold
27,728
– – ﹤0.01% 335
2025
Q3 		$5.77K Hold
27,728
– – ﹤0.01% 301
2025
Q2 		$6.17K Hold
27,728
– – ﹤0.01% 293
2025
Q1 		$5.98K Sell
27,728
-2,207
-7% -$732 ﹤0.01% 239
2024
Q4 		$12.3K Hold
29,935
– – ﹤0.01% 241
2024
Q3 		$5.54K Hold
29,935
– – ﹤0.01% 309
2024
Q2 		$6.22K Hold
29,935
– – ﹤0.01% 336
2024
Q1 		$3.13K Hold
29,935
– – ﹤0.01% 373
2023
Q4 		$11.2K Hold
29,935
– – ﹤0.01% 408
2023
Q3 		$7.49K Hold
29,935
– – ﹤0.01% 514
2023
Q2 		$19K Hold
29,935
– – ﹤0.01% 499
2023
Q1 		$14.5K Hold
29,935
– – ﹤0.01% 666
2022
Q4 		$15.7K Buy
+29,935
New +$19.1K ﹤0.01% 763

Other funds holding SRTAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Saba Capital Management's SRTAW Position: Q1 2026 in Review

Saba Capital Management held its Strata Critical Medical Inc Warrants (SRTAW) position steady in Q1 2026 at 27,728 shares worth $183. The position accounts for ﹤0.01% of the portfolio, ranked #390.

Saba Capital Management first reported a position in SRTAW in Q4 2022 and has held it in 14 quarters since. The position peaked at $19K in Q2 2023. 8 funds tracked by Wall St. Rank hold SRTAW as of Q1 2026.

  • Saba Capital Management held 27,728 shares of Strata Critical Medical Inc Warrants worth $183 as of Q1 2026.
  • Saba Capital Management left its Strata Critical Medical Inc Warrants share count unchanged in Q1 2026.
  • Strata Critical Medical Inc Warrants made up ﹤0.01% of Saba Capital Management's portfolio in Q1 2026, its #390 holding.
  • Saba Capital Management first reported a position in Strata Critical Medical Inc Warrants in Q4 2022 and has held it in 14 quarters since.
  • Saba Capital Management's Strata Critical Medical Inc Warrants position peaked at $19K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q1 2026.

Based on Saba Capital Management's 13F filing for Q1 2026, filed 15 May 2026.